From: ESR1 and EGFgenetic variation in relation to breast cancer risk and survival
Haplotype proportions | ||||
---|---|---|---|---|
TAGs 26–30 | Haplotypes | Cases (n = 1,579a) | Controls (n = 1,514a) | OR (95% CI) |
Haplotype 1 | ACAAC | 0.57 | 0.56 | 1.00 (Reference) |
Haplotype 2 | GTGGT | 0.09 | 0.10 | 0.91 (0.76–1.09) |
Haplotype 3 | ACAGC | 0.06 | 0.06 | 1.05 (0.84–1.31) |
Haplotype 4 | ATGGT | 0.06 | 0.06 | 0.89 (0.70–1.13) |
Haplotype 5 | ATGGC | 0.06 | 0.05 | 1.05 (0.82–1.35) |
Haplotype 6 | GTGGC | 0.05 | 0.03 | 1.46 (1.08–1.98) |
Haplotype 7 | GTAAC | 0.03 | 0.04 | 0.72 (0.55–0.96) |
Rareb | 0.08 | 0.08 | 0.94 (0.76–1.15) | |
Global p valuec | 0.0493 |